Clinical Trial Update: Diagnostic Validity of [18F]FSPG PET for the Assessment of Disease Activity in Inflammatory Bowel Disease [Phase 2]

View source ↗

Summary

Phase 2 trial assessing the diagnostic validity of 18F-FSPG PET for disease activity in inflammatory bowel diseases including ulcerative colitis and Crohn disea…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease
• Inflammatory Bowel Disease
• Ulcerative Colitis

Drugs mentioned

• 18F-FSPG

Snippet

Sponsor: Asan Foundation | Conditions: Inflammatory Bowel Diseases, Ulcerative Colitis | Phase 2 | Status: COMPLETED